Target intelligence / Profile preview

RNA, U6 small nuclear 22, pseudogene (RNU6-22P)

Target
RNU6-22P
Molecular classification
Other, Pseudogene
01

Overview

RNA, U6 small nuclear 22, pseudogene (RNU6-22P) is a human gene annotated as a pseudogene, meaning it shares sequence similarity to functional U6 small nuclear RNA genes but does not produce a functional RNA or protein. It is catalogued in genome databases (HGNC:34266, NCBI Gene:106478917, Ensembl:ENSG00000207083). U6 snRNA genes code for small nuclear RNAs involved in the spliceosome and intron removal from pre-mRNA, but pseudogenes like RNU6-22P have lost this functionality, either because they are not expressed or because their sequence is no longer capable of fold and function. In the context of molecular targeting, RNU6-22P does not serve as an enzyme, receptor, transporter, or therapeutic target. If you seek information about functional U6 small nuclear RNA, review canonical U6 snRNA gene entries such as RNU6-1, which is involved in pre-mRNA splicing and has biological and biomarker relevance. However, RNU6-22P itself does not have direct biological or clinical significance.

Other names
RNU6-22RNU6-22P
02

Mechanism of action

None (no mechanisms of action relevant to this pseudogene)

03

Biological functions

None (pseudogenes do not encode functional products; functional U6 snRNA is involved in splicing, but RNU6-22P itself is non-functional)
04

Disease associations

None (no direct implication as a disease gene, risk factor, or biomarker from available sources)
05

Safety considerations

None (no safety concerns are associated with modulation of this pseudogene; clinical relevance is lacking)
06

Interacting drugs

None (no known drugs interact with RNU6-22P)
07

Biomarkers

None (RNU6-22P is not used as a biomarker; functional U6 snRNA species are sometimes used as reference controls, but not this pseudogene)

Beyond the preview

Go deeper on RNA, U6 small nuclear 22, pseudogene (RNU6-22P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 22, pseudogene (RNU6-22P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call